學術活動

講題    ：How to Build Strategic Alliance Strategie

主講人  ：林榮錦  董事長     (台灣東洋藥品工業股份有限公司)

授課老師：國立中山大學資訊管理學系  黃慶祥  教授

時間    ：2003/11/06  15:00~17:00

地點    ：管理學院 4112

About  TTY BIOPHARM Co., Ltd

TTY positions itself as one of the most innovative biopharmaceutical companies in Asia. The major disease categories we focus on are oncology, CV, AIR, GI and chest diseases. Our core strength includes the late stage development (formulation and clinical studies) as well as the brand marketing of new drugs. TTY aims to be the best strategic partner of international biopharmaceutical companies for clinical studies and marketing in Asia.

In order to expanding our international marketing, TTY is looking for strategic alliance with international companies by technical and marketing collaboration as well as exchange medical information. The target markets of the alliances are countries in Asia, especially China and Taiwan.

In Taiwan, TTY cooperates with National Health Research Institute, Development Center of Biotechnology, Taiwan Liposome Co., medical centers and teaching hospitals.

The long-term operating strategy will focus on the development of its key disease categories including the drugs for the treatment of cancer, cardio-vascular diseases, chest diseases, gastro-intestinal diseases, and orthopedics. In the area of technology, TTY will keep focusing on the development of sustained release, liposomal, and anti-cancer drugs.